These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol. Mehlsen J; Trap-Jensen J Eur Heart J; 1990 Apr; 11 Suppl A():56-8. PubMed ID: 1971593 [TBL] [Abstract][Full Text] [Related]
3. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension. Mehlsen J; Trap-Jensen J Acta Med Scand; 1986; 219(2):173-7. PubMed ID: 2870611 [TBL] [Abstract][Full Text] [Related]
4. Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Man in 't Veld AJ; Schalekamp MA Br Med J (Clin Res Ed); 1981 Mar; 282(6268):929-31. PubMed ID: 6781656 [TBL] [Abstract][Full Text] [Related]
5. A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy. Leslie PJ; Thompson C; Clarke BF; Ewing DJ Clin Auton Res; 1991 Jun; 1(2):119-23. PubMed ID: 1688039 [TBL] [Abstract][Full Text] [Related]
6. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects. Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200 [TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function. Rousseau MF; Pouleur H; Debaisieux JC; Van Eyll C; Charlier AA Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):84S-85S. PubMed ID: 2572264 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
9. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome). West JN; Stallard TJ; Dimmitt SB; Smith SA; Williams A; Littler WA Q J Med; 1990 Feb; 74(274):209-13. PubMed ID: 1971724 [TBL] [Abstract][Full Text] [Related]
10. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers. Tangø M; Carlsen JE; Trap-Jensen J Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963 [TBL] [Abstract][Full Text] [Related]
11. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest. Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751 [TBL] [Abstract][Full Text] [Related]
12. No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study. Dejgård A; Hilsted J Diabetologia; 1988 May; 31(5):281-4. PubMed ID: 3294067 [TBL] [Abstract][Full Text] [Related]
13. Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction. Molajo AO; Bennett DH Br Heart J; 1985 Jul; 54(1):17-21. PubMed ID: 2861834 [TBL] [Abstract][Full Text] [Related]
15. Endogenous and exogenous agonist regulation of responses to beta-adrenoceptor stimulation in patients with chronic autonomic failure. Man in 't Veld AJ; Schalekamp MA Clin Exp Pharmacol Physiol; 1982; 9(3):271-5. PubMed ID: 6291825 [TBL] [Abstract][Full Text] [Related]
16. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. McCaffrey PM; Riddell JG; Shanks RG Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634 [TBL] [Abstract][Full Text] [Related]
17. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. Lammers JW; Müller ME; Folgering HT; van Herwaarden CL Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680 [TBL] [Abstract][Full Text] [Related]
18. Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol. Jennings G; Bobik A; Oddie C; Restall R Clin Pharmacol Ther; 1984 May; 35(5):594-603. PubMed ID: 6143634 [TBL] [Abstract][Full Text] [Related]
19. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure. Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233 [TBL] [Abstract][Full Text] [Related]
20. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure. Virk SJ; Davies MK Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]